Gerasimova, E.; Popkova, T.V.; Kirillova, I.G.; Gerasimova, D.; Nasonov, E.L.; Lila, A.M.
Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on “Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425”. Int. J. Mol. Sci. 2025, 26, 2953.
https://doi.org/10.3390/ijms26072953
AMA Style
Gerasimova E, Popkova TV, Kirillova IG, Gerasimova D, Nasonov EL, Lila AM.
Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on “Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425”. International Journal of Molecular Sciences. 2025; 26(7):2953.
https://doi.org/10.3390/ijms26072953
Chicago/Turabian Style
Gerasimova, Elena, Tatiana V. Popkova, Irina G. Kirillova, Daria Gerasimova, Evgenii L. Nasonov, and Aleksandr M. Lila.
2025. "Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on “Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425”" International Journal of Molecular Sciences 26, no. 7: 2953.
https://doi.org/10.3390/ijms26072953
APA Style
Gerasimova, E., Popkova, T. V., Kirillova, I. G., Gerasimova, D., Nasonov, E. L., & Lila, A. M.
(2025). Reply to Saleh, C.; Budincevic, H. Interleukin-6, Tocilizumab and Atherosclerosis. Comment on “Gerasimova et al. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425”. International Journal of Molecular Sciences, 26(7), 2953.
https://doi.org/10.3390/ijms26072953
